Clinical trial
A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in…
NCT00297804 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00297804 |
|---|---|
| Title | A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions |
| Official title | TAXUS VI - A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions |
| Acronym | TAXUS VI |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | TAXUS Express Paclitaxel-Eluting Coronary Stent System, Control stent |
| Enrollment | 448 |
| Start date | May 1, 2002 |
| Primary completion | Oct 1, 2003 |
| Completion | Feb 1, 2008 |
| First posted | Mar 1, 2006 |
| Last update posted | Apr 21, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: